检索结果 - Stephanie Cardarella

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    The Impact of Genomic Changes on Treatment of Lung Cancer

    The Impact of Genomic Changes on Treatment of Lung Cancer 由 Stephanie Cardarella, Bruce E. Johnson

    出版 2013
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  2. 2
    Five-Year Survival in EGFR -Mutant Metastatic Lung Adenocarcinoma Treated with EGFR-TKIs

    Five-Year Survival in EGFR -Mutant Metastatic Lung Adenocarcinoma Treated with EGFR-TKIs 由 W. Marston Linehan, Stephanie Cardarella, Christine Lydon, Suzanne E. Dahlberg, David M. Jackman, Pasi A. Jänne, Bruce E. Johnson

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Tumor Volume Decrease at 8 Weeks Is Associated with Longer Survival in EGFR-Mutant Advanced Non–Small-Cell Lung Cancer Patients Treated with EGFR TKI

    Tumor Volume Decrease at 8 Weeks Is Associated with Longer Survival in EGFR-Mutant Advanced Non–Small-Cell Lung Cancer Patients Treated with EGFR TKI 由 Mizuki Nishino, Suzanne E. Dahlberg, Stephanie Cardarella, David M. Jackman, Michael S. Rabin, Hiroto Hatabu, Pasi A. Jänne, Bruce E. Johnson

    出版 2013
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Interstitial lung abnormalities in treatment-naïve advanced non-small-cell lung cancer patients are associated with shorter survival

    Interstitial lung abnormalities in treatment-naïve advanced non-small-cell lung cancer patients are associated with shorter survival 由 Mizuki Nishino, Stephanie Cardarella, Suzanne E. Dahlberg, Tetsuro Araki, Christine Lydon, David M. Jackman, Michael S. Rabin, Hiroto Hatabu, Bruce E. Johnson

    出版 2015
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Radiographic assessment and therapeutic decisions at RECIST progression in EGFR-mutant NSCLC treated with EGFR tyrosine kinase inhibitors

    Radiographic assessment and therapeutic decisions at RECIST progression in EGFR-mutant NSCLC treated with EGFR tyrosine kinase inhibitors 由 Mizuki Nishino, Stephanie Cardarella, Suzanne E. Dahlberg, David M. Jackman, Nikhil H. Ramaiya, Hiroto Hatabu, Michael S. Rabin, Pasi A. Jnne, Bruce E. Johnson

    出版 2012
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Clinical, Pathologic, and Biologic Features Associated with <i>BRAF</i> Mutations in Non–Small Cell Lung Cancer

    Clinical, Pathologic, and Biologic Features Associated with <i>BRAF</i> Mutations in Non–Small Cell Lung Cancer 由 Stephanie Cardarella, Atsuko Ogino, Mizuki Nishino, Mohit Butaney, Jeanne Shen, Christine Lydon, Beow Y. Yeap, Lynette M. Sholl, Bruce E. Johnson, Pasi A. Jänne

    出版 2013
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    The Introduction of Systematic Genomic Testing for Patients with Non–Small-Cell Lung Cancer

    The Introduction of Systematic Genomic Testing for Patients with Non–Small-Cell Lung Cancer 由 Stephanie Cardarella, Taylor M. Ortiz, Victoria A. Joshi, Mohit Butaney, David M. Jackman, David J. Kwiatkowski, Beow Y. Yeap, Pasi A. Jänne, Neal I. Lindeman, Bruce E. Johnson

    出版 2012
    获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: